Group One Trading
TARO

Group One Trading’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Group One Trading’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,500
Closed -$1.84M – 8680
2021
Q1 		$1.84M Hold
2,500
– – ﹤0.01% 2548
2020
Q4 		$184K Buy
+2,500
New +$161K ﹤0.01% 4113

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading's TARO Position: Q1 2021 in Review

Group One Trading sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2021, closing a stake of 982 shares — an estimated $74.6K sold.

Group One Trading first reported a position in TARO in Q4 2019 and held it in 3 quarters. The position peaked at $537K in Q4 2019. 80 funds tracked by Wall St. Rank hold TARO as of Q1 2021.

  • Group One Trading reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2021 after selling out during the quarter.
  • Group One Trading sold 982 Taro Pharmaceutical Industries Ltd. shares in Q1 2021, an estimated $74.6K.
  • Group One Trading first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2019 and held it in 3 quarters.
  • Group One Trading's Taro Pharmaceutical Industries Ltd. position peaked at $537K in Q4 2019.
  • 80 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2021.

Based on Group One Trading's 13F filing for Q1 2021, filed 12 May 2021.